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Abstract
In this study, we detected new sequence variations in LAMA2 and SGCG genes in 5 ethnic populations, and ana-
lysed their effect on enhancer composition and mRNA structure. PCR amplification and DNA sequencing were per-
formed and followed by bioinformatics analyses using ESEfinder as well as MFOLD software. We found 3 novel
sequence variations in the LAMA2 (c.3174+22_23insAT and c.6085 +12delA) and SGCG (c.
*102A/C) genes. These
variations were present in 210 tested healthy controls from Tunisian, Moroccan, Algerian, Lebanese and French
populations suggesting that they represent novel polymorphisms within LAMA2 and SGCG genes sequences.
ESEfinder showed that the c.
*102A/C substitution created a new exon splicing enhancer in the 3’UTR of SGCG
genes, whereas the c.6085 +12delA deletion was situated in the base pairing region between LAMA2 mRNA and the
U1snRNA spliceosomal components. The RNA structure analyses showed that both variations modulated RNA sec-
ondary structure. Our results are suggestive of correlations between mRNA folding and the recruitment of
spliceosomal components mediating splicing, including SR proteins. The contribution of common sequence varia-
tions to mRNA structural and functional diversity will contribute to a better study of gene expression.
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Introduction
Whole-genome sequencing of many organisms is
producing enormous amounts of data, useful in elucidating
the transcriptional regulatory mechanisms of genes. More-
over, comparative sequence analysis of non-coding ele-
ments has helped to find new regulatory elements within
many genes. New motifs have been discovered from
evolutionarilyconservedregions(Wassermanetal.,2000),
alistofco-regulatedgenes(Rothetal.,1998),orfromalist
of functionally related genes (Elkon et al., 2003).
Pre-messenger RNA (mRNA) splicing requires the
accurate recognition of splice sites by cellular RNA pro-
cessing machinery. In addition to sequences that comprise
thebranchpointandthe3’and5’splicesites,cellularsplic-
ing machinery relies on additional information in the form
of exonic and intronic splicing enhancer and silencer se-
quences (Zhang et al., 2009). Splicing enhancers are dis-
cretesequencesof6or8nucleotidesthatpromotebothcon-
stitutive and regulated splicing, and facilitate exon
definitionbyassistingintherecruitmentofsplicingfactors,
especially SR proteins (serine/ arginine-rich proteins)
(Chasin, 2007). Ominously, recent studies predict that
many human genetic diseases linked to genetic polymor-
phisms might be caused by the inactivation of splicing
enhancers (Wang et al., 2005).
Single nucleotide polymorphisms (SNPs) represent
the most frequent type of DNA sequence variations that
causephenotypicvariabilitythroughmultiplemechanisms,
this including changes in the encoded protein sequence, the
effect on gene regulation, mRNA processing (splicing,
mRNA modification and turnover), and translation (Niel-
sen et al., 2007). The last few years have seen extensive ef-
forts to catalogue human genetic variations and correlate
them with phenotypic differences and gene expression.
Studies on the impact of genetic variation in mRNA pro-
cessing have not been sufficiently investigated, especially
as it has been documented that a number of neutral genetic
variations alter or create essential sequence elements for
splicing and mRNA processing (Byrne et al., 2009). These
seemingly neutral variations are associated with altered
length and/or the steady-state level of cytoplasmic mRNA
(Zhang et al., 2007; Hofmann et al., 2008).
We studied the LAMA2 and SGCG genes responsible
for the MDC1A and LGMD2C forms of muscular dystro-
phies, respectively. Limb girdle muscular dystrophies
(LGMD(s)) include a heterogeneous group of progressive
muscular dystrophy mainly affecting the pelvic and shoul-
der girdle musculature. 50% of LGMD cases are sarco-
glycanopathies related to mutations in SGCA, SGCB,
SGCD and SGCG genes, thereby leading to the LGMD2D,
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Research ArticleLGMD2E, LGMD2F and LGMD2C forms respectively
(Guglieri et al., 2005; Daniele et al., 2007). Mutations in
LAMA2geneareknowntobeinvolvedintheMDC1Aform
representingthatwhichismostfrequentincasesofcongen-
ital muscular dystrophy. MDC1A is generally character-
ized by Total deficiency laminin 2 encoding by the
LAMA2 gene, this leading to a severe phenotype marked by
neonatal generalized hypotonia and weakness, with no in-
dependent ambulation due to severe contracture (Tome et
al., 1994; Helbling-Leclerc et al., 1995). Moreover, over
the latter years and from recent studies, there is proof of the
presence of mutations in the LAMA2 gene in some late-
onset LGMD forms, where mutations do not result in the
complete absence of laminin 2, but in the production of
truncated proteins or in increased proteolytic degradation
(Naom et al., 1998).
We report here three novel homozygous sequence
variations found in the setting of an extensive sequencing
of LAMA2 and SGCG genes in two Tunisian patients with
autosomic recessive LGMD. These variations were found
in 210 tested controls from five different Mediterranean
populations (Tunisian, Moroccan, Algerian, Lebanese and
French). Two of these variations modulated cis-acting reg-
ulatory elements of LAMA2 and SGCG genes and have po-
tential to modify their RNA secondary structure.
Subjects and Methods
Subjects
New sequence variations were screened in 62 unre-
lated healthy Tunisian individuals, 50 unrelated controls
from Morocco, 45 unrelated healthy controls from Algeria,
35 controls from Lebanon and 20 healthy French individu-
als. Blood samples were collected after receiving informed
consent from all subjects and with the approval of the ap-
propriate Ethic Committees.
DNA extraction
Total genomic DNA was isolated from blood leuco-
cytes samples of the tested individuals, according to the
previously described protocol of Kawasaki (1990).
PCR amplification and DNA sequencing of LAMA2
and SGCG genes
PCR amplification of the 65 exons of the LAMA2
genewasperformedusingappropriatelychosenprimers,so
that at least 30 to 50 bp of flanking intronic sequences be-
came readable. For this, a thermal cycler (GeneAmp PCR
system 9700, Applied Biosystem) was used, applying the
touchdown method as previously described (Guicheney et
al., 1998). The 8 SGCG gene exons were amplified using
primers from LMDP (Leiden Muscular Dystrophy Pages),
under optimized PCR conditions consisting of 0.1 go f
genomic DNA, 5 L of 10 X buffer (50 mM Tris-HCl, pH
9.2, 160 mM (NH4)2 SO4, 22.5 mM MgCl2, 2% DMSO,
and 1% Tween 20), 10 mM dNTP, 20 pmol of each primer
and2UofTaqDNApolymerase.DirectsequencingofPCR
productswasperformedwiththeABIPrismBigDyetermi-
natorcyclesequencingReadyReactionKit(ABIPrism/PE
Biosystems), and the products were resolved on ABI Prism
3100-Avant. Blast searches were performed using the
NCBI database.
Computational analyses
Bioinformatic web-based tools were used for predict-
ing the effect of the new detected variations on enhancer
composition and RNA secondary structure of the LAMA2
and SGCG genes. Two distinct softwares for analyzing
splicing enhancers in detected polymorphisms were em-
ployed. In fact, ESEfinder 3.0 (Cartegni et al., 2003), was
specifically designed for identifying exonic splicing
enhancers, and we used it for the c.*102A/C situated in the
3’UTRwhichisanexonicuntranslatedregion.Whereasfor
the other c.3174+22_23insAT and c.6085 +12delA
polymorphisms which are situated in intronic regions
(intron 22 and 42 of the LAMA2 gene, respectively); we
used the enhancerfinder program (Cartegni et al., 2003).
However, the positive and negative results are independent
of the software used. Prediction of their effect on the RNA
secondary structure was through the MFOLD program
(Zuker, 1994).
Results
Novel sequence variations in the LAMA2 and SGCG
genes
Sequencing of the LAMA2 and SGCG genes was per-
formed with the aim to search for sequence variations in
two patients with autosomic recessive LGMD. No muta-
tions were found in either gene in the two patients tested.
However, novel sequence variations in the LAMA2 and
SGCG genes were detected. We revealed the presence of 2
novel homozygous intronic sequence variations in the
LAMA2 gene. The first was an (AT) insertion at position
+23 of intron 22 (c.3174+22_23insAT; dbSNP accession
number: ss 142460322), whereas the second was a deletion
ofanadeninatposition+12ofintron42oftheLAMA2gene
(c.6085 +12delA; dbSNP accession number: ss
142460323)(Figure1a).IntheSGCGgene,anewhomozy-
gous A to C substitution at position +102 in the 3’UTR re-
gion was revealed (c.
*102A/C; dbSNP accession number:
ss 142460324). These sequences were different from those
published in the last release of the NCBI GenBank (Figu-
re 1b). Screening of these variations in the LAMA2 and
SGCG genes in 60 unrelated healthy Tunisian controls
from different regions revealed their presence in the homo-
zygous state in all the tested subjects (Table 1).
This result prompted us to search for these sequence
variations on four other ethnic populations. We screened
Siala et al. 191two populations from North Africa, this including 50 heal-
thyMoroccanand45Algeriancontrols,besidesindividuals
from two other Mediterranen populations, namely 35
Libanese and 20 healthy French controls. We found that
100% of the healthy individuals tested were homozygous
for the three sequence variations (Table 1).
Effect of sequence variations on cis-acting
regulatory elements
The ESEfinder program showed that the c.
*102A/C
substitutionispredictedtocreateanexonsplicingenhancer
in the 3’UTR of the SGCG gene. The new exon splicing
enhancer is a GGGACGT which is predicted to be recog-
nized by the SF2/ASF SR protein with a score of 3.96, thus
significantly higher than the threshold value of 1.956 (Fig-
ure 2). c.3174+22_23insAT and c.6085+12delA intronic
variations in the LAMA2 gene were predicted not to affect
enhancer composition. However, the c.6085+12delA was
found to be localised in the donor splicing consensus of
intron 42, which mediated a base pairing complementarity
with the U1snRNA spliceosomal component (Figure 3b).
Correlation between cis-acting elements and RNA
secondary structure
InordertostudywhetherpremRNAfoldingcouldbe
influenced by the presence of these sequence variations in
theLAMA2andSGCGgenes,weperformedbioinformatics
analyses using the MFOLD program. The results strongly
suggested that the c.3174+22_23insAT in intron 22 of
LAMA2 had no marked effect on RNA structure (Figure
3a). However, RNA structure analyses of intron 42 and
flanking exons (exons 42 and 43) showed that the
c.6085+12delAinthedonorsplicingconsensusofintron42
of LAMA2 (Figure 3b) was followed by several structural
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Figure 1 - Novel genetic variations in LAMA2 and SGCG genes. Sequencing of the LAMA2 gene revealed two novel intronic variations: a
c.3174+22_23insAT insertion in intron 22 and a c.6085+12delA deletion in intron 42. Sequencing of SGCG gene revealed anA>Csubstitution at posi-
tion +102 in the 3’UTR region.changes (Figure 3c). In fact, detailed RNA structure analy-
ses of the 5’ splicing consensus showed that the original se-
quence contained an external closing pair between G
12C
21
with a hairpin loop between those G
13 and C
20 positions
containinganAatposition6085.Thec.6085+12delAdele-
tionshiftsthe8bpexternalhairpinloopbetweenC
6andG
13
positions, and changes its nucleotide composition, when
compared to the original sequence. Moreover, the orienta-
tion of the external loop was modified (Figure 3d).
The creation of an exon splicing enhancer following
c.
*102A/C substitution in 3’UTRs of SGCG is predicted to
create many changes in RNA secondary structure, as to the
number, position and orientation of the various external
loops (Figure 4a, 4b).
Discussion
The regulatory mechanisms involved in gene expres-
sion became an important aspect of genomics revealed by
the completed genome sequencing of many organisms.
Most common SNPs have now been assessed in ge-
nome-wide studies for statistical associations with many
complex traits, these including many important and com-
mon diseases (Roeder and Luca, 2009). Although these
studies have provided new biological insights, only a lim-
Siala et al. 193
Figure 2 - Computational prediction of the effect of c.
*102A/C change on enhancer composition. (a) The A at position +102 of the 3’UTR of the SGCG
genedoesnotincludeanESE.(b)NotethattheAtoCsubstitutioncreatesanewenhancerinthe3’UTRoftheSGCGgenerecognizedbytheSF2/ASFSR
protein. The arrows indicate the SNP position.
Table 1 - Genotypes of novel SNPs found in the LAMA2 and SGCG genes tested in five ethnic populations.
LAMA2 gene (intron 22) LAMA2 gene (intron 42) SGCG gene (3’UTR)
Original sequence c.3174+22_23insAT c.6085 +12A c.6085 +12delA c.
*102A/C c.
*102A/C
Tunisian population (n = 60) 0% 100% 0% 100% 0% 100%
Moroccan population (n = 50) 0% 100% 0% 100% 0% 100%
Algerian population (n = 45) 0% 100% 0% 100% 0% 100%
Libanese population (n = 35) 0% 100% 0% 100% 0% 100%
French population (n = 20) 0% 100% 0% 100% 0% 100%
Note that all the tested individuals are homozygous for the novel sequence variations.ited knowledge of SNPs within regulatory gene elements
affecting mRNA post-transcriptional processing has been
acquired.
In this study, we discovered three novel sequence
variations in the LAMA2 and SGCG genes present in 100%
of the 155 healthy tested individuals from North Africa, in-
cluding Tunisian, Algerian and Moroccan populations and
in the 35 and 20 controls from the Lebanon and France, re-
spectively. These results indicate that the
c.3174+22_23insATinsertionandc.6085+12delAdeletion
in LAMA2, as well as the c.
*102A/C substitution in SGCG
were not only specific to North African, but also apply to
other Mediterranean populations. We thus emphasize that
these novel sequence variants represent novel
polymorphisms in the GenBank sequences of the LAMA2
and SGCG genes.
Intron removal during pre-mRNA splicing in higher
eukaryotes requires the accurate identification of the two
splice sites at the ends of the exons or in the intron: the
exon/intron definition (House and Lynch, 2008). This im-
194 Sequence variations in LAMA2 and SGCG genes
Figure3-Proposedsecondary-structuremodelsofthenewsequencevariationsinLAMA2genes.(a)Thec.3174+22_23insATinintron22oftheLAMA2
genewaspredictednottoaffectRNAsecondarystructure.(b)Positionofthec.6085delAinLAMA2.Thedeletionissituatedatposition+12inthe5’con-
sensus splice site of intron 42. The c.6085delA is underlined. Position +1 indicates the first nucleotide of the 5’ splice site of exon 42. (c) Comparison of
RNA secondary structure of [exon 42 + intron 42 + exon 43] between the original sequence and the c.6085+12delA bearing sequence. Several structural
changes were predicted. The arrows indicate modifications in folding. (d) Detailed RNA structure analysis of the 5’ splicing consensus. The originals e -
quence contained an external closing pair between G
12C
21 with a hairpin loop between the G
13 and C
20 positions containing an A at position 6085. The
c.6085+12delA deletion shifts the 8 bp external hairpin loop and induced a change in its nucleotide composition. Moreover, orientation of the external
loop was modified.portant task is executed in the nucleus by the spliceosome
which is assembled at the correct donor and acceptor splice
sites. Moreover, additional information is provided by
cis-acting regulatory sequences that serve to enhance or re-
press splicing, the splicing enhancers and the splicing si-
lencers, respectively (Cartegni et al., 2003).
In our study, the ESEfinder program predicted that
c.
*102A/C created a new enhancer in the 3’UTR of SGCG.
In the LAMA2 gene, the c.3174+22_23insAT did not affect
the regulatory elements of the gene itself. On the other
hand,c.6085+12delAmaydisruptbasepairingbetweenthe
donor splicing consensus of intron 42 of LAMA2 pre
mRNA and the 5’ end of U1snRNA, this recognition being
crucial for U6snRNP recruitment (Lund and Kjems, 2002).
The importance of this region was also confirmed in our
previous studies which demonstrated thata7b pdeletion
from position +5 to +11 in the donor splicing consensus of
intron 17 of the LAMA2 gene triggered total skipping of
exon 17 (Siala et al., 2008). Moreover, the position +12 in
the 5’ splicing consensus has already been demonstrated to
be determinant for the correct mRNA processing of the
ATM gene through its interaction with the U1snRNA
(Lewandowska et al., 2005).
The 3’ UTR contains regulatory elements that are es-
sential for appropriate expression of many genes. These
regulatory elements are involved in the control of nuclear
transport (Ding and Lipshitz, 1993), the polyadenylation
status and sub-cellular targeting (St Johnston, 1995), as
well as in the rates of translation and degradation of mRNA
by the NMD (nonsense mediated mRNA decay) system
(Sachs,1993).Theseprocessesaremediatedbytheinterac-
tion of specific sequences in 3’ UTRs with specific RNA
binding proteins. The creation of an enhancer in the 3’UTR
also emphasizes alterations in the splicing pattern and
mRNA stability of the SGCG transcript. In fact, it could
also be responsible of the synthesis of an alternative
isoformofSGCGmRNA.Thisideawasalreadyreportedin
HLA-Gtranscript(Rousseauetal.,2003)andinthemRNA
encoding the -catalytic subunit of the mitochondrial H
+-
ATP synthase, where translation enhancing activity gener-
ates a new isoform, depending upon the cell type analysed
(Di Liegro et al., 2000).
These results suggest a possible functional role for
both c.6085+12delA and c.
*102A/C in pre mRNA stability
andsplicingprocessingoftheLAMA2andSGCGgenes,re-
spectively. The localisation of human coding and non-
coding variations in splicing consensus or enhancers, as
well as their effect on mRNA splicing has already been re-
ported in several studies (Fairbrother et al., 2004).
The bioinformatics analyses performed to evaluate the
effect of these sequence variations on RNA secondary struc-
ture showed that the c.3174+22_23insAT is predicted not to
affect the RNA structure, whereas the c.6085+12delA inser-
tion in intron 42 of the LAMA2 gene, as well as the
c.
*102A/C in the 3’UTR of the SGCG gene is predicted to
generate several alterations in RNA secondary structure
compared to the original sequences. This correlation be-
tween RNA structure and cis-acting regulatory elements can
be explained by pre-mRNA folding within these regions be-
ing crucial for their binding to SR proteins (serine/arginine
rich proteins), and may be important for the recruitment of
spliceosomal components mediating splicing. Indeed, a
growingbodyofevidencehasshownthatmRNAfoldingin-
fluencedawiderangeoftranscriptionevents,suchasmRNA
splicing (Sheng and Tinoco, 1995), processing (Allain et al.,
1996), translational control (Pelletier and Sonenberg, 1987)
and regulation (Addess et al., 1997).
In conclusion, in this study we reported 3 novel se-
quence variations in the LAMA2 and SGCG gene se-
quences, two of which predicted to modulate cis-acting
regulatory elements and RNA secondary structure. Se-
quence variations were retrieved in all the healthy controls
tested, thereby indicating their not being involved in dis-
ease susceptibility or phenotypic variability. Indeed, the
contribution of common sequence variation to mRNA
structural and functional diversity could provide an insight
into the fundamental mechanisms of gene expression.
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